1. Home
  2. AWRE vs UBX Comparison

AWRE vs UBX Comparison

Compare AWRE & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • UBX
  • Stock Information
  • Founded
  • AWRE 1986
  • UBX 2009
  • Country
  • AWRE United States
  • UBX United States
  • Employees
  • AWRE N/A
  • UBX N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • UBX Health Care
  • Exchange
  • AWRE Nasdaq
  • UBX Nasdaq
  • Market Cap
  • AWRE 35.2M
  • UBX 38.6M
  • IPO Year
  • AWRE 1996
  • UBX 2018
  • Fundamental
  • Price
  • AWRE $1.58
  • UBX $1.94
  • Analyst Decision
  • AWRE
  • UBX Strong Buy
  • Analyst Count
  • AWRE 0
  • UBX 2
  • Target Price
  • AWRE N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • AWRE 44.8K
  • UBX 330.9K
  • Earning Date
  • AWRE 03-11-2025
  • UBX 11-04-2024
  • Dividend Yield
  • AWRE N/A
  • UBX N/A
  • EPS Growth
  • AWRE N/A
  • UBX N/A
  • EPS
  • AWRE N/A
  • UBX N/A
  • Revenue
  • AWRE $16,966,000.00
  • UBX N/A
  • Revenue This Year
  • AWRE $10.98
  • UBX N/A
  • Revenue Next Year
  • AWRE N/A
  • UBX $33.62
  • P/E Ratio
  • AWRE N/A
  • UBX N/A
  • Revenue Growth
  • AWRE N/A
  • UBX N/A
  • 52 Week Low
  • AWRE $1.35
  • UBX $0.94
  • 52 Week High
  • AWRE $2.97
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 45.55
  • UBX 50.03
  • Support Level
  • AWRE $1.54
  • UBX $1.81
  • Resistance Level
  • AWRE $1.78
  • UBX $2.39
  • Average True Range (ATR)
  • AWRE 0.12
  • UBX 0.27
  • MACD
  • AWRE -0.01
  • UBX -0.06
  • Stochastic Oscillator
  • AWRE 20.00
  • UBX 12.50

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: